Long-term survival and clinical outcomes of delayed chest closure following lung transplantation
© 2024. The Author(s)..
PURPOSES: Delayed chest closure (DCC) is a widely accepted procedure in the context of lung transplantation (LTx); yet there are few reports detailing its long-term survival and clinical outcomes.
METHODS: We reviewed the medical records of recipients who underwent deceased-donor lung transplantation (LTx) at Tohoku University Hospital. Long-term survival, including overall survival, freedom from chronic lung allograft dysfunction (CLAD), and CLAD-free survival and the clinical outcomes of graft function and physical performance and constitution were reviewed in recipients with DCC.
RESULTS: Between 2009 and 2022, 116 patients underwent LTx, 33 of whom (28.4%) required DCC. The intra-and post-operative courses of the recipients who required DCC were more complicated than those of the recipients who underwent primary chest closure (PCC), with frequent volume reduction surgery and longer periods of invasive mechanical ventilation. Pulmonary vascular disease was considered a risk factor for these complications and DCC. Nonetheless, long-term survival and graft functions were comparable between the DCC and PCC groups. The physical performance and constitution of recipients who required DCC continued to improve, and by 2 years after transplantation, exhibited almost no difference from those who underwent PCC.
CONCLUSIONS: In view of the profoundly complicated intra- and post-operative courses, DCC should be performed cautiously and only when clinically indicated, despite which it can result in equivalent long-term survival and acceptable outcomes to PCC.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
|---|---|
| Enthalten in: |
Surgery today - (2024) vom: 28. März |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hirama, Takashi [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Chronic lung allograft dysfunction |
|---|
| Anmerkungen: |
Date Revised 28.03.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1007/s00595-024-02821-1 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370363981 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370363981 | ||
| 003 | DE-627 | ||
| 005 | 20240330002611.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240330s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00595-024-02821-1 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1355.xml |
| 035 | |a (DE-627)NLM370363981 | ||
| 035 | |a (NLM)38546861 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hirama, Takashi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Long-term survival and clinical outcomes of delayed chest closure following lung transplantation |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 28.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a © 2024. The Author(s). | ||
| 520 | |a PURPOSES: Delayed chest closure (DCC) is a widely accepted procedure in the context of lung transplantation (LTx); yet there are few reports detailing its long-term survival and clinical outcomes | ||
| 520 | |a METHODS: We reviewed the medical records of recipients who underwent deceased-donor lung transplantation (LTx) at Tohoku University Hospital. Long-term survival, including overall survival, freedom from chronic lung allograft dysfunction (CLAD), and CLAD-free survival and the clinical outcomes of graft function and physical performance and constitution were reviewed in recipients with DCC | ||
| 520 | |a RESULTS: Between 2009 and 2022, 116 patients underwent LTx, 33 of whom (28.4%) required DCC. The intra-and post-operative courses of the recipients who required DCC were more complicated than those of the recipients who underwent primary chest closure (PCC), with frequent volume reduction surgery and longer periods of invasive mechanical ventilation. Pulmonary vascular disease was considered a risk factor for these complications and DCC. Nonetheless, long-term survival and graft functions were comparable between the DCC and PCC groups. The physical performance and constitution of recipients who required DCC continued to improve, and by 2 years after transplantation, exhibited almost no difference from those who underwent PCC | ||
| 520 | |a CONCLUSIONS: In view of the profoundly complicated intra- and post-operative courses, DCC should be performed cautiously and only when clinically indicated, despite which it can result in equivalent long-term survival and acceptable outcomes to PCC | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Chronic lung allograft dysfunction | |
| 650 | 4 | |a Delayed chest closure | |
| 650 | 4 | |a Lung transplant | |
| 650 | 4 | |a Outcome | |
| 650 | 4 | |a Physical performance | |
| 650 | 4 | |a Survival | |
| 700 | 1 | |a Akiba, Miki |e verfasserin |4 aut | |
| 700 | 1 | |a Ui, Masahiro |e verfasserin |4 aut | |
| 700 | 1 | |a Shibata, Saori |e verfasserin |4 aut | |
| 700 | 1 | |a Tomiyama, Fumiko |e verfasserin |4 aut | |
| 700 | 1 | |a Watanabe, Tatsuaki |e verfasserin |4 aut | |
| 700 | 1 | |a Watanabe, Yui |e verfasserin |4 aut | |
| 700 | 1 | |a Notsuda, Hirotsugu |e verfasserin |4 aut | |
| 700 | 1 | |a Suzuki, Takaya |e verfasserin |4 aut | |
| 700 | 1 | |a Oishi, Hisashi |e verfasserin |4 aut | |
| 700 | 1 | |a Niikawa, Hiromichi |e verfasserin |4 aut | |
| 700 | 1 | |a Noda, Masafumi |e verfasserin |4 aut | |
| 700 | 1 | |a Okada, Yoshinori |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Surgery today |d 1997 |g (2024) vom: 28. März |w (DE-627)NLM012623938 |x 1436-2813 |7 nnns |
| 773 | 1 | 8 | |g year:2024 |g day:28 |g month:03 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00595-024-02821-1 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 28 |c 03 | ||